Last update :
19/11/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Immunosuppressant   Infliximab  
injection
Eye-drops
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Flixabi Belgium, Germany, Great Britain, Spain
Flixceli Peru
Inflectra Belgium, Canada, Germany, Great Britain, Iceland, Italy, Romania, Spain, Switzerland
Infliximab Chile
Remicade Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Denmark, Ecuador, Finland, France, Germany, Great Britain, Greece, Iceland, Iran, Ireland, Italy, Japan, Luxembourg, Malaysia, Mexico, Netherlands, New Zealand, Norway, Peru, Poland, Portugal, Romania, Saudi Arabia, Spain, Sweden, Switzerland, Tunisia, Turkey, United Arab Emirates, United States of America, Venezuela
Remsima Argentina, Belgium, Canada, Chile, Ecuador, France, Germany, Great Britain, Iceland, Italy, Norway, Peru, Romania, Spain, Switzerland, Turkey
Zessli Belgium, Germany, Great Britain
Stability in solutions   injection   Stability in solutions : Infliximab     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Water for Injection 10 mg/ml 2-8°C Not specified
28 Day
754
Manufacturer's stability data
Glass Water for Injection 10 mg/ml 2-8°C Not specified
14 Day
4279
Level of evidence A+
Glass Water for Injection 10 mg/ml 2-8°C Not specified
14 Day
4279
Level of evidence A+ 		Biosimilar
Glass Water for Injection 10 mg/ml 2-8°C Not specified
30 Day
4292
Level of evidence A+ 		Biosimilar
Glass Water for Injection 10 mg/ml 23-27°C Not specified
14 Day
4292
Level of evidence A+ 		Biosimilar
Glass Water for Injection 10 mg/ml 25°C Protect from light
7 Day
4003
Level of evidence A+ 		Biosimilar
Glass Water for Injection 10 mg/ml 25°C Protect from light
7 Day
4049
Level of evidence B+ 		Biosimilar
Glass Water for Injection 10 mg/ml 4°C Protect from light
35 Day
3137

Glass Water for Injection 10 mg/ml 5°C Protect from light
60 Day
4003
Level of evidence A+ 		Biosimilar
Glass Water for Injection 10 mg/ml 5°C Protect from light
14 Day
4049
Level of evidence B+ 		Biosimilar
Glass Water for Injection 50 mg/ml 4°C Protect from light
35 Day
3137

Polyvinyl chloride Sodium chloride 0,9% 0.4 mg/ml 4°C Not specified
14 Day
3333
Biological analysis
Polyethylene Sodium chloride 0,9% 0,4 mg/ml 2-8°C Not specified
30 Day
4292
Level of evidence A+ 		Biosimilar
Polyethylene Sodium chloride 0,9% 0,4 mg/ml 23-27°C Not specified
30 Day
4292
Level of evidence A+ 		Biosimilar
Polyethylene Sodium chloride 0,9% 0,96 mg/ml 25°C Protect from light
7 Day
4003
Level of evidence A+ 		Biosimilar
Polyethylene Sodium chloride 0,9% 0,96 mg/ml 5°C Protect from light
7 Day
4003
Level of evidence A+ 		Biosimilar
Polyethylene Sodium chloride 0,9% 1,2 mg/ml 25°C Protect from light
7 Day
4003
Level of evidence A+ 		Biosimilar
Polyethylene Sodium chloride 0,9% 1,2 mg/ml 5°C Protect from light
7 Day
4003
Level of evidence A+ 		Biosimilar
Polyethylene Sodium chloride 0,9% 1,6 mg/ml 25°C Protect from light
7 Day
4003
Level of evidence A+ 		Biosimilar
Polyethylene Sodium chloride 0,9% 1,6 mg/ml 5°C Protect from light
7 Day
4003
Level of evidence A+ 		Biosimilar
Polyethylene Sodium chloride 0,9% 4 mg/ml 2-8°C Not specified
30 Day
4292
Level of evidence A+ 		Biosimilar
Polyethylene Sodium chloride 0,9% 4 mg/ml 23-27°C Not specified
30 Day
4292
Level of evidence A+ 		Biosimilar
Polyolefine Sodium chloride 0,9% 0,4 mg/ml 2-8°C Not specified
14 Day
4279
Level of evidence A+ 		Biosimilar
Polyolefine Sodium chloride 0,9% 0,4 mg/ml 2-8°C Not specified
14 Day
4279
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,7 mg/ml 22°C Not specified
30 Day
3317
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,7 mg/ml 25°C Protect from light
7 Day
3924
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,7 mg/ml 4°C Not specified
30 Day
3317
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,7 mg/ml 4°C Protect from light
7 Day
3924
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0.4 mg/ml 25°C Protect from light
30 Day
4049
Level of evidence B+ 		Biosimilar
Polyolefine Sodium chloride 0,9% 0.4 mg/ml 5°C Protect from light
90 Day
4049
Level of evidence B+ 		Biosimilar
Polyolefine Sodium chloride 0,9% 0.6 & 0.84 & 1.88 mg/ml 2-8°C Protect from light
7 Day
3825
Level of evidence A+ 		Biosimilar
Polyolefine Sodium chloride 0,9% 0.6 & 0.84 & 1.88 mg/ml 25°C Light
7 Day
3825
Level of evidence A+ 		Biosimilar
Polyolefine Sodium chloride 0,9% 1,6 mg/ml 22°C Not specified
30 Day
3317
Level of evidence A+
Polyolefine Sodium chloride 0,9% 1,6 mg/ml 25°C Protect from light
7 Day
3924
Level of evidence A+
Polyolefine Sodium chloride 0,9% 1,6 mg/ml 4°C Not specified
30 Day
3317
Level of evidence A+
Polyolefine Sodium chloride 0,9% 1,6 mg/ml 4°C Protect from light
7 Day
3924
Level of evidence A+
Polyolefine Sodium chloride 0,9% 2 mg/ml 2-8°C Not specified
14 Day
4279
Level of evidence A+
Polyolefine Sodium chloride 0,9% 2 mg/ml 2-8°C Not specified
14 Day
4279
Level of evidence A+ 		Biosimilar
Polyolefine Sodium chloride 0,9% 2 mg/ml 25°C Protect from light
30 Day
4049
Level of evidence B+ 		Biosimilar
Polyolefine Sodium chloride 0,9% 2 mg/ml 5°C Protect from light
90 Day
4049
Level of evidence B+ 		Biosimilar
Not specified Sodium chloride 0,9% < 4 mg/ml 2-8°C Not specified
28 Day
754
Manufacturer's stability data
  Mentions Légales